Skip to main content
. 2020 Dec 10;147(4):1031–1040. doi: 10.1007/s00432-020-03486-2

Fig. 2.

Fig. 2

Kaplan–Meier survival analysis (log-rank test) considering the median survival depending on the GATA6 status of the patients. No significant GATA6-depending survival differences were observed within a the entire cohort (p = 0.212) as well as b those patients after neoadjuvant treatment (p = 0.699) while the subgroup of GATA6-positive patients without neoadjuvant therapy c showed a significant better postsurgical survival (p = 0.032)